SPONSOR
Kalpna Kay Durairaj, MD, FACS
Total Trials
1
Recruiting
1
Phases
Phase 4
Conditions studied: Volume Loss (Soft Tissue Ptosis or Atrophy )
Kalpna Kay Durairaj, MD, FACS is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Volume Loss (Soft Tissue Ptosis or Atrophy ).
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Kalpna Kay Durairaj, MD, FACS
How many clinical trials has Kalpna Kay Durairaj, MD, FACS sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Kalpna Kay Durairaj, MD, FACS, of which 1 are actively recruiting participants. These trials cover conditions including Volume Loss (Soft Tissue Ptosis or Atrophy ). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Kalpna Kay Durairaj, MD, FACS research focus on?
Kalpna Kay Durairaj, MD, FACS clinical trials span Volume Loss (Soft Tissue Ptosis or Atrophy ). The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Kalpna Kay Durairaj, MD, FACS clinical trial?
To participate in a Kalpna Kay Durairaj, MD, FACS trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Kalpna Kay Durairaj, MD, FACS trials with current recruitment status updated daily.
Clinical Trials by Kalpna Kay Durairaj, MD, FACS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology